Fig. 3From: An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary interventionIncidence of Ischemic, Bleeding Events and NACE Stratified by Platelet Reactivity. (a) Incidence of Ischemic events; (b) Incidence of Bleeding events; (c) Incidence of NACE. *P < 0.05; **P < 0.001. PLADP, ADP induced platelet aggregation; NACE, net adverse clinical events; IW, inside the window; OW, outside the windowBack to article page